开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2127322, encodeId=1d6d212e32245, content=请问一下综述类型的文章接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ff28193581, createdName=ms9000000592309820, createdTime=Thu Apr 20 20:30:56 CST 2023, time=2023-04-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=583771, encodeId=b456583e71f5, content=请问不是妇产科肿瘤，其他方向肿瘤可以投吗132****5832暂无昵称 2019-10-25 发表:: 收版面费132****5832暂无昵称 2019-10-25 00:00:00 发表: 收版面费, beContent=132****5832暂无昵称 2019-10-25 发表:: 收版面费, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86e72409573, createdName=12372b09m38暂无昵称, createdTime=Wed Jan 22 00:00:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577053, encodeId=d4875e7053ce, content=杂志审稿很快，一个半月收到二审结果，一审是两位审稿人，结论小修。二审是副编辑，结论小修。想问一下，大家也是这样，两位reviewer，一位副编辑AE吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e89f5151116, createdName=14697d06m38(暂无昵称), createdTime=Sat Sep 28 09:10:00 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089489, encodeId=aafa108948975, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089490, encodeId=7e9a108949051, content=讨论中如何凸显文章创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574557, encodeId=fd575e455732, content=请问这个statement agreement是什么啊，上传文档的下拉菜单里没有这个东西，投稿不成功啊Aimee2014 2018-05-29 发表:: 我5月23日投稿，1周了还没有稿号，这个杂志多久给稿号啊，其他杂志都没那么久呀Aimee2014 2018-05-29 13:11:00 发表: 我5月23日投稿，1周了还没有稿号，这个杂志多久给稿号啊，其他杂志都没那么久呀, beContent=Aimee2014 2018-05-29 发表:: 我5月23日投稿，1周了还没有稿号，这个杂志多久给稿号啊，其他杂志都没那么久呀, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7d75122049, createdName=lovefyzz, createdTime=Thu Aug 08 00:00:00 CST 2019, time=2019-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586533, encodeId=267e586533a0, content=三月九号投的，11号就收到消息给拒了，不是妇科肿瘤建议不要投155****7827暂无昵称 2020-03-08 00:00:00 发表: 请问不是妇科肿瘤可以投吗, beContent=155****7827暂无昵称 2020-03-08 00:00:00 发表: 请问不是妇科肿瘤可以投吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e7d5293588, createdName=1486b608m27暂无昵称, createdTime=Fri Mar 13 00:00:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601011, encodeId=681360101124, content=个案是不是只接受约稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da515265462, createdName=1480fa6cm87暂无昵称, createdTime=Mon Jun 01 16:11:36 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586183, encodeId=b409586183ca, content=请问不是妇科肿瘤可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e7d5293588, createdName=1486b608m27暂无昵称, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578501, encodeId=b8785e850104, content=收版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2023-04-20 ms9000000592309820 来自山东省

请问一下综述类型的文章接收吗？

93 0

[GetPortalCommentsPageByObjectIdResponse(id=2127322, encodeId=1d6d212e32245, content=请问一下综述类型的文章接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ff28193581, createdName=ms9000000592309820, createdTime=Thu Apr 20 20:30:56 CST 2023, time=2023-04-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=583771, encodeId=b456583e71f5, content=请问不是妇产科肿瘤，其他方向肿瘤可以投吗132****5832暂无昵称 2019-10-25 发表:: 收版面费132****5832暂无昵称 2019-10-25 00:00:00 发表: 收版面费, beContent=132****5832暂无昵称 2019-10-25 发表:: 收版面费, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86e72409573, createdName=12372b09m38暂无昵称, createdTime=Wed Jan 22 00:00:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577053, encodeId=d4875e7053ce, content=杂志审稿很快，一个半月收到二审结果，一审是两位审稿人，结论小修。二审是副编辑，结论小修。想问一下，大家也是这样，两位reviewer，一位副编辑AE吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e89f5151116, createdName=14697d06m38(暂无昵称), createdTime=Sat Sep 28 09:10:00 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089489, encodeId=aafa108948975, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089490, encodeId=7e9a108949051, content=讨论中如何凸显文章创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574557, encodeId=fd575e455732, content=请问这个statement agreement是什么啊，上传文档的下拉菜单里没有这个东西，投稿不成功啊Aimee2014 2018-05-29 发表:: 我5月23日投稿，1周了还没有稿号，这个杂志多久给稿号啊，其他杂志都没那么久呀Aimee2014 2018-05-29 13:11:00 发表: 我5月23日投稿，1周了还没有稿号，这个杂志多久给稿号啊，其他杂志都没那么久呀, beContent=Aimee2014 2018-05-29 发表:: 我5月23日投稿，1周了还没有稿号，这个杂志多久给稿号啊，其他杂志都没那么久呀, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7d75122049, createdName=lovefyzz, createdTime=Thu Aug 08 00:00:00 CST 2019, time=2019-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586533, encodeId=267e586533a0, content=三月九号投的，11号就收到消息给拒了，不是妇科肿瘤建议不要投155****7827暂无昵称 2020-03-08 00:00:00 发表: 请问不是妇科肿瘤可以投吗, beContent=155****7827暂无昵称 2020-03-08 00:00:00 发表: 请问不是妇科肿瘤可以投吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e7d5293588, createdName=1486b608m27暂无昵称, createdTime=Fri Mar 13 00:00:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601011, encodeId=681360101124, content=个案是不是只接受约稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da515265462, createdName=1480fa6cm87暂无昵称, createdTime=Mon Jun 01 16:11:36 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586183, encodeId=b409586183ca, content=请问不是妇科肿瘤可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e7d5293588, createdName=1486b608m27暂无昵称, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578501, encodeId=b8785e850104, content=收版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2020-01-22 12372b09m38暂无昵称

请问不是妇产科肿瘤，其他方向肿瘤可以投吗132****5832暂无昵称 2019-10-25 发表::
收版面费132****5832暂无昵称 2019-10-25 00:00:00 发表:
收版面费

132****5832暂无昵称 2019-10-25 发表:: 收版面费

311 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2127322, encodeId=1d6d212e32245, content=请问一下综述类型的文章接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ff28193581, createdName=ms9000000592309820, createdTime=Thu Apr 20 20:30:56 CST 2023, time=2023-04-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=583771, encodeId=b456583e71f5, content=请问不是妇产科肿瘤，其他方向肿瘤可以投吗132****5832暂无昵称 2019-10-25 发表:: 收版面费132****5832暂无昵称 2019-10-25 00:00:00 发表: 收版面费, beContent=132****5832暂无昵称 2019-10-25 发表:: 收版面费, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86e72409573, createdName=12372b09m38暂无昵称, createdTime=Wed Jan 22 00:00:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577053, encodeId=d4875e7053ce, content=杂志审稿很快，一个半月收到二审结果，一审是两位审稿人，结论小修。二审是副编辑，结论小修。想问一下，大家也是这样，两位reviewer，一位副编辑AE吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e89f5151116, createdName=14697d06m38(暂无昵称), createdTime=Sat Sep 28 09:10:00 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089489, encodeId=aafa108948975, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089490, encodeId=7e9a108949051, content=讨论中如何凸显文章创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574557, encodeId=fd575e455732, content=请问这个statement agreement是什么啊，上传文档的下拉菜单里没有这个东西，投稿不成功啊Aimee2014 2018-05-29 发表:: 我5月23日投稿，1周了还没有稿号，这个杂志多久给稿号啊，其他杂志都没那么久呀Aimee2014 2018-05-29 13:11:00 发表: 我5月23日投稿，1周了还没有稿号，这个杂志多久给稿号啊，其他杂志都没那么久呀, beContent=Aimee2014 2018-05-29 发表:: 我5月23日投稿，1周了还没有稿号，这个杂志多久给稿号啊，其他杂志都没那么久呀, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7d75122049, createdName=lovefyzz, createdTime=Thu Aug 08 00:00:00 CST 2019, time=2019-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586533, encodeId=267e586533a0, content=三月九号投的，11号就收到消息给拒了，不是妇科肿瘤建议不要投155****7827暂无昵称 2020-03-08 00:00:00 发表: 请问不是妇科肿瘤可以投吗, beContent=155****7827暂无昵称 2020-03-08 00:00:00 发表: 请问不是妇科肿瘤可以投吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e7d5293588, createdName=1486b608m27暂无昵称, createdTime=Fri Mar 13 00:00:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601011, encodeId=681360101124, content=个案是不是只接受约稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da515265462, createdName=1480fa6cm87暂无昵称, createdTime=Mon Jun 01 16:11:36 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586183, encodeId=b409586183ca, content=请问不是妇科肿瘤可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e7d5293588, createdName=1486b608m27暂无昵称, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578501, encodeId=b8785e850104, content=收版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2019-09-28 14697d06m38(暂无昵称)

杂志审稿很快，一个半月收到二审结果，一审是两位审稿人，结论小修。二审是副编辑，结论小修。想问一下，大家也是这样，两位reviewer，一位副编辑AE吗？

327 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2127322, encodeId=1d6d212e32245, content=请问一下综述类型的文章接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ff28193581, createdName=ms9000000592309820, createdTime=Thu Apr 20 20:30:56 CST 2023, time=2023-04-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=583771, encodeId=b456583e71f5, content=请问不是妇产科肿瘤，其他方向肿瘤可以投吗132****5832暂无昵称 2019-10-25 发表:: 收版面费132****5832暂无昵称 2019-10-25 00:00:00 发表: 收版面费, beContent=132****5832暂无昵称 2019-10-25 发表:: 收版面费, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86e72409573, createdName=12372b09m38暂无昵称, createdTime=Wed Jan 22 00:00:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577053, encodeId=d4875e7053ce, content=杂志审稿很快，一个半月收到二审结果，一审是两位审稿人，结论小修。二审是副编辑，结论小修。想问一下，大家也是这样，两位reviewer，一位副编辑AE吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e89f5151116, createdName=14697d06m38(暂无昵称), createdTime=Sat Sep 28 09:10:00 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089489, encodeId=aafa108948975, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089490, encodeId=7e9a108949051, content=讨论中如何凸显文章创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574557, encodeId=fd575e455732, content=请问这个statement agreement是什么啊，上传文档的下拉菜单里没有这个东西，投稿不成功啊Aimee2014 2018-05-29 发表:: 我5月23日投稿，1周了还没有稿号，这个杂志多久给稿号啊，其他杂志都没那么久呀Aimee2014 2018-05-29 13:11:00 发表: 我5月23日投稿，1周了还没有稿号，这个杂志多久给稿号啊，其他杂志都没那么久呀, beContent=Aimee2014 2018-05-29 发表:: 我5月23日投稿，1周了还没有稿号，这个杂志多久给稿号啊，其他杂志都没那么久呀, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7d75122049, createdName=lovefyzz, createdTime=Thu Aug 08 00:00:00 CST 2019, time=2019-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586533, encodeId=267e586533a0, content=三月九号投的，11号就收到消息给拒了，不是妇科肿瘤建议不要投155****7827暂无昵称 2020-03-08 00:00:00 发表: 请问不是妇科肿瘤可以投吗, beContent=155****7827暂无昵称 2020-03-08 00:00:00 发表: 请问不是妇科肿瘤可以投吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e7d5293588, createdName=1486b608m27暂无昵称, createdTime=Fri Mar 13 00:00:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601011, encodeId=681360101124, content=个案是不是只接受约稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da515265462, createdName=1480fa6cm87暂无昵称, createdTime=Mon Jun 01 16:11:36 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586183, encodeId=b409586183ca, content=请问不是妇科肿瘤可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e7d5293588, createdName=1486b608m27暂无昵称, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578501, encodeId=b8785e850104, content=收版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2021-12-28 Gym璨烨

讨论中我和之前发表文章结果不一致怎么处理？

174 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2127322, encodeId=1d6d212e32245, content=请问一下综述类型的文章接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ff28193581, createdName=ms9000000592309820, createdTime=Thu Apr 20 20:30:56 CST 2023, time=2023-04-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=583771, encodeId=b456583e71f5, content=请问不是妇产科肿瘤，其他方向肿瘤可以投吗132****5832暂无昵称 2019-10-25 发表:: 收版面费132****5832暂无昵称 2019-10-25 00:00:00 发表: 收版面费, beContent=132****5832暂无昵称 2019-10-25 发表:: 收版面费, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86e72409573, createdName=12372b09m38暂无昵称, createdTime=Wed Jan 22 00:00:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577053, encodeId=d4875e7053ce, content=杂志审稿很快，一个半月收到二审结果，一审是两位审稿人，结论小修。二审是副编辑，结论小修。想问一下，大家也是这样，两位reviewer，一位副编辑AE吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e89f5151116, createdName=14697d06m38(暂无昵称), createdTime=Sat Sep 28 09:10:00 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089489, encodeId=aafa108948975, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089490, encodeId=7e9a108949051, content=讨论中如何凸显文章创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574557, encodeId=fd575e455732, content=请问这个statement agreement是什么啊，上传文档的下拉菜单里没有这个东西，投稿不成功啊Aimee2014 2018-05-29 发表:: 我5月23日投稿，1周了还没有稿号，这个杂志多久给稿号啊，其他杂志都没那么久呀Aimee2014 2018-05-29 13:11:00 发表: 我5月23日投稿，1周了还没有稿号，这个杂志多久给稿号啊，其他杂志都没那么久呀, beContent=Aimee2014 2018-05-29 发表:: 我5月23日投稿，1周了还没有稿号，这个杂志多久给稿号啊，其他杂志都没那么久呀, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7d75122049, createdName=lovefyzz, createdTime=Thu Aug 08 00:00:00 CST 2019, time=2019-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586533, encodeId=267e586533a0, content=三月九号投的，11号就收到消息给拒了，不是妇科肿瘤建议不要投155****7827暂无昵称 2020-03-08 00:00:00 发表: 请问不是妇科肿瘤可以投吗, beContent=155****7827暂无昵称 2020-03-08 00:00:00 发表: 请问不是妇科肿瘤可以投吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e7d5293588, createdName=1486b608m27暂无昵称, createdTime=Fri Mar 13 00:00:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601011, encodeId=681360101124, content=个案是不是只接受约稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da515265462, createdName=1480fa6cm87暂无昵称, createdTime=Mon Jun 01 16:11:36 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586183, encodeId=b409586183ca, content=请问不是妇科肿瘤可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e7d5293588, createdName=1486b608m27暂无昵称, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578501, encodeId=b8785e850104, content=收版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2021-12-27 ms6000000264964247

讨论中如何凸显文章创新性？

158 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2127322, encodeId=1d6d212e32245, content=请问一下综述类型的文章接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ff28193581, createdName=ms9000000592309820, createdTime=Thu Apr 20 20:30:56 CST 2023, time=2023-04-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=583771, encodeId=b456583e71f5, content=请问不是妇产科肿瘤，其他方向肿瘤可以投吗132****5832暂无昵称 2019-10-25 发表:: 收版面费132****5832暂无昵称 2019-10-25 00:00:00 发表: 收版面费, beContent=132****5832暂无昵称 2019-10-25 发表:: 收版面费, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86e72409573, createdName=12372b09m38暂无昵称, createdTime=Wed Jan 22 00:00:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577053, encodeId=d4875e7053ce, content=杂志审稿很快，一个半月收到二审结果，一审是两位审稿人，结论小修。二审是副编辑，结论小修。想问一下，大家也是这样，两位reviewer，一位副编辑AE吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e89f5151116, createdName=14697d06m38(暂无昵称), createdTime=Sat Sep 28 09:10:00 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089489, encodeId=aafa108948975, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089490, encodeId=7e9a108949051, content=讨论中如何凸显文章创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574557, encodeId=fd575e455732, content=请问这个statement agreement是什么啊，上传文档的下拉菜单里没有这个东西，投稿不成功啊Aimee2014 2018-05-29 发表:: 我5月23日投稿，1周了还没有稿号，这个杂志多久给稿号啊，其他杂志都没那么久呀Aimee2014 2018-05-29 13:11:00 发表: 我5月23日投稿，1周了还没有稿号，这个杂志多久给稿号啊，其他杂志都没那么久呀, beContent=Aimee2014 2018-05-29 发表:: 我5月23日投稿，1周了还没有稿号，这个杂志多久给稿号啊，其他杂志都没那么久呀, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7d75122049, createdName=lovefyzz, createdTime=Thu Aug 08 00:00:00 CST 2019, time=2019-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586533, encodeId=267e586533a0, content=三月九号投的，11号就收到消息给拒了，不是妇科肿瘤建议不要投155****7827暂无昵称 2020-03-08 00:00:00 发表: 请问不是妇科肿瘤可以投吗, beContent=155****7827暂无昵称 2020-03-08 00:00:00 发表: 请问不是妇科肿瘤可以投吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e7d5293588, createdName=1486b608m27暂无昵称, createdTime=Fri Mar 13 00:00:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601011, encodeId=681360101124, content=个案是不是只接受约稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da515265462, createdName=1480fa6cm87暂无昵称, createdTime=Mon Jun 01 16:11:36 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586183, encodeId=b409586183ca, content=请问不是妇科肿瘤可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e7d5293588, createdName=1486b608m27暂无昵称, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578501, encodeId=b8785e850104, content=收版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2019-08-08 lovefyzz

请问这个statement agreement是什么啊，上传文档的下拉菜单里没有这个东西，投稿不成功啊Aimee2014 2018-05-29 发表::
我5月23日投稿，1周了还没有稿号，这个杂志多久给稿号啊，其他杂志都没那么久呀Aimee2014 2018-05-29 13:11:00 发表:
我5月23日投稿，1周了还没有稿号，这个杂志多久给稿号啊，其他杂志都没那么久呀

Aimee2014 2018-05-29 发表:: 我5月23日投稿，1周了还没有稿号，这个杂志多久给稿号啊，其他杂志都没那么久呀

324 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2127322, encodeId=1d6d212e32245, content=请问一下综述类型的文章接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ff28193581, createdName=ms9000000592309820, createdTime=Thu Apr 20 20:30:56 CST 2023, time=2023-04-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=583771, encodeId=b456583e71f5, content=请问不是妇产科肿瘤，其他方向肿瘤可以投吗132****5832暂无昵称 2019-10-25 发表:: 收版面费132****5832暂无昵称 2019-10-25 00:00:00 发表: 收版面费, beContent=132****5832暂无昵称 2019-10-25 发表:: 收版面费, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86e72409573, createdName=12372b09m38暂无昵称, createdTime=Wed Jan 22 00:00:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577053, encodeId=d4875e7053ce, content=杂志审稿很快，一个半月收到二审结果，一审是两位审稿人，结论小修。二审是副编辑，结论小修。想问一下，大家也是这样，两位reviewer，一位副编辑AE吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e89f5151116, createdName=14697d06m38(暂无昵称), createdTime=Sat Sep 28 09:10:00 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089489, encodeId=aafa108948975, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089490, encodeId=7e9a108949051, content=讨论中如何凸显文章创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574557, encodeId=fd575e455732, content=请问这个statement agreement是什么啊，上传文档的下拉菜单里没有这个东西，投稿不成功啊Aimee2014 2018-05-29 发表:: 我5月23日投稿，1周了还没有稿号，这个杂志多久给稿号啊，其他杂志都没那么久呀Aimee2014 2018-05-29 13:11:00 发表: 我5月23日投稿，1周了还没有稿号，这个杂志多久给稿号啊，其他杂志都没那么久呀, beContent=Aimee2014 2018-05-29 发表:: 我5月23日投稿，1周了还没有稿号，这个杂志多久给稿号啊，其他杂志都没那么久呀, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7d75122049, createdName=lovefyzz, createdTime=Thu Aug 08 00:00:00 CST 2019, time=2019-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586533, encodeId=267e586533a0, content=三月九号投的，11号就收到消息给拒了，不是妇科肿瘤建议不要投155****7827暂无昵称 2020-03-08 00:00:00 发表: 请问不是妇科肿瘤可以投吗, beContent=155****7827暂无昵称 2020-03-08 00:00:00 发表: 请问不是妇科肿瘤可以投吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e7d5293588, createdName=1486b608m27暂无昵称, createdTime=Fri Mar 13 00:00:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601011, encodeId=681360101124, content=个案是不是只接受约稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da515265462, createdName=1480fa6cm87暂无昵称, createdTime=Mon Jun 01 16:11:36 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586183, encodeId=b409586183ca, content=请问不是妇科肿瘤可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e7d5293588, createdName=1486b608m27暂无昵称, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578501, encodeId=b8785e850104, content=收版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2020-03-13 1486b608m27暂无昵称

三月九号投的，11号就收到消息给拒了，不是妇科肿瘤建议不要投155****7827暂无昵称 2020-03-08 00:00:00 发表:
请问不是妇科肿瘤可以投吗

155****7827暂无昵称 2020-03-08 00:00:00 发表: 请问不是妇科肿瘤可以投吗

274 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2127322, encodeId=1d6d212e32245, content=请问一下综述类型的文章接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ff28193581, createdName=ms9000000592309820, createdTime=Thu Apr 20 20:30:56 CST 2023, time=2023-04-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=583771, encodeId=b456583e71f5, content=请问不是妇产科肿瘤，其他方向肿瘤可以投吗132****5832暂无昵称 2019-10-25 发表:: 收版面费132****5832暂无昵称 2019-10-25 00:00:00 发表: 收版面费, beContent=132****5832暂无昵称 2019-10-25 发表:: 收版面费, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86e72409573, createdName=12372b09m38暂无昵称, createdTime=Wed Jan 22 00:00:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577053, encodeId=d4875e7053ce, content=杂志审稿很快，一个半月收到二审结果，一审是两位审稿人，结论小修。二审是副编辑，结论小修。想问一下，大家也是这样，两位reviewer，一位副编辑AE吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e89f5151116, createdName=14697d06m38(暂无昵称), createdTime=Sat Sep 28 09:10:00 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089489, encodeId=aafa108948975, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089490, encodeId=7e9a108949051, content=讨论中如何凸显文章创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574557, encodeId=fd575e455732, content=请问这个statement agreement是什么啊，上传文档的下拉菜单里没有这个东西，投稿不成功啊Aimee2014 2018-05-29 发表:: 我5月23日投稿，1周了还没有稿号，这个杂志多久给稿号啊，其他杂志都没那么久呀Aimee2014 2018-05-29 13:11:00 发表: 我5月23日投稿，1周了还没有稿号，这个杂志多久给稿号啊，其他杂志都没那么久呀, beContent=Aimee2014 2018-05-29 发表:: 我5月23日投稿，1周了还没有稿号，这个杂志多久给稿号啊，其他杂志都没那么久呀, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7d75122049, createdName=lovefyzz, createdTime=Thu Aug 08 00:00:00 CST 2019, time=2019-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586533, encodeId=267e586533a0, content=三月九号投的，11号就收到消息给拒了，不是妇科肿瘤建议不要投155****7827暂无昵称 2020-03-08 00:00:00 发表: 请问不是妇科肿瘤可以投吗, beContent=155****7827暂无昵称 2020-03-08 00:00:00 发表: 请问不是妇科肿瘤可以投吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e7d5293588, createdName=1486b608m27暂无昵称, createdTime=Fri Mar 13 00:00:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601011, encodeId=681360101124, content=个案是不是只接受约稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da515265462, createdName=1480fa6cm87暂无昵称, createdTime=Mon Jun 01 16:11:36 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586183, encodeId=b409586183ca, content=请问不是妇科肿瘤可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e7d5293588, createdName=1486b608m27暂无昵称, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578501, encodeId=b8785e850104, content=收版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2020-06-01 1480fa6cm87暂无昵称

个案是不是只接受约稿

6 0

[GetPortalCommentsPageByObjectIdResponse(id=2127322, encodeId=1d6d212e32245, content=请问一下综述类型的文章接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ff28193581, createdName=ms9000000592309820, createdTime=Thu Apr 20 20:30:56 CST 2023, time=2023-04-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=583771, encodeId=b456583e71f5, content=请问不是妇产科肿瘤，其他方向肿瘤可以投吗132****5832暂无昵称 2019-10-25 发表:: 收版面费132****5832暂无昵称 2019-10-25 00:00:00 发表: 收版面费, beContent=132****5832暂无昵称 2019-10-25 发表:: 收版面费, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86e72409573, createdName=12372b09m38暂无昵称, createdTime=Wed Jan 22 00:00:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577053, encodeId=d4875e7053ce, content=杂志审稿很快，一个半月收到二审结果，一审是两位审稿人，结论小修。二审是副编辑，结论小修。想问一下，大家也是这样，两位reviewer，一位副编辑AE吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e89f5151116, createdName=14697d06m38(暂无昵称), createdTime=Sat Sep 28 09:10:00 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089489, encodeId=aafa108948975, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089490, encodeId=7e9a108949051, content=讨论中如何凸显文章创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574557, encodeId=fd575e455732, content=请问这个statement agreement是什么啊，上传文档的下拉菜单里没有这个东西，投稿不成功啊Aimee2014 2018-05-29 发表:: 我5月23日投稿，1周了还没有稿号，这个杂志多久给稿号啊，其他杂志都没那么久呀Aimee2014 2018-05-29 13:11:00 发表: 我5月23日投稿，1周了还没有稿号，这个杂志多久给稿号啊，其他杂志都没那么久呀, beContent=Aimee2014 2018-05-29 发表:: 我5月23日投稿，1周了还没有稿号，这个杂志多久给稿号啊，其他杂志都没那么久呀, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7d75122049, createdName=lovefyzz, createdTime=Thu Aug 08 00:00:00 CST 2019, time=2019-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586533, encodeId=267e586533a0, content=三月九号投的，11号就收到消息给拒了，不是妇科肿瘤建议不要投155****7827暂无昵称 2020-03-08 00:00:00 发表: 请问不是妇科肿瘤可以投吗, beContent=155****7827暂无昵称 2020-03-08 00:00:00 发表: 请问不是妇科肿瘤可以投吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e7d5293588, createdName=1486b608m27暂无昵称, createdTime=Fri Mar 13 00:00:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601011, encodeId=681360101124, content=个案是不是只接受约稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da515265462, createdName=1480fa6cm87暂无昵称, createdTime=Mon Jun 01 16:11:36 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586183, encodeId=b409586183ca, content=请问不是妇科肿瘤可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e7d5293588, createdName=1486b608m27暂无昵称, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578501, encodeId=b8785e850104, content=收版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2020-03-08 1486b608m27暂无昵称

请问不是妇科肿瘤可以投吗

254 0

[GetPortalCommentsPageByObjectIdResponse(id=2127322, encodeId=1d6d212e32245, content=请问一下综述类型的文章接收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ff28193581, createdName=ms9000000592309820, createdTime=Thu Apr 20 20:30:56 CST 2023, time=2023-04-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=583771, encodeId=b456583e71f5, content=请问不是妇产科肿瘤，其他方向肿瘤可以投吗132****5832暂无昵称 2019-10-25 发表:: 收版面费132****5832暂无昵称 2019-10-25 00:00:00 发表: 收版面费, beContent=132****5832暂无昵称 2019-10-25 发表:: 收版面费, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86e72409573, createdName=12372b09m38暂无昵称, createdTime=Wed Jan 22 00:00:00 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577053, encodeId=d4875e7053ce, content=杂志审稿很快，一个半月收到二审结果，一审是两位审稿人，结论小修。二审是副编辑，结论小修。想问一下，大家也是这样，两位reviewer，一位副编辑AE吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e89f5151116, createdName=14697d06m38(暂无昵称), createdTime=Sat Sep 28 09:10:00 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089489, encodeId=aafa108948975, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089490, encodeId=7e9a108949051, content=讨论中如何凸显文章创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574557, encodeId=fd575e455732, content=请问这个statement agreement是什么啊，上传文档的下拉菜单里没有这个东西，投稿不成功啊Aimee2014 2018-05-29 发表:: 我5月23日投稿，1周了还没有稿号，这个杂志多久给稿号啊，其他杂志都没那么久呀Aimee2014 2018-05-29 13:11:00 发表: 我5月23日投稿，1周了还没有稿号，这个杂志多久给稿号啊，其他杂志都没那么久呀, beContent=Aimee2014 2018-05-29 发表:: 我5月23日投稿，1周了还没有稿号，这个杂志多久给稿号啊，其他杂志都没那么久呀, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7d75122049, createdName=lovefyzz, createdTime=Thu Aug 08 00:00:00 CST 2019, time=2019-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586533, encodeId=267e586533a0, content=三月九号投的，11号就收到消息给拒了，不是妇科肿瘤建议不要投155****7827暂无昵称 2020-03-08 00:00:00 发表: 请问不是妇科肿瘤可以投吗, beContent=155****7827暂无昵称 2020-03-08 00:00:00 发表: 请问不是妇科肿瘤可以投吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e7d5293588, createdName=1486b608m27暂无昵称, createdTime=Fri Mar 13 00:00:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601011, encodeId=681360101124, content=个案是不是只接受约稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da515265462, createdName=1480fa6cm87暂无昵称, createdTime=Mon Jun 01 16:11:36 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586183, encodeId=b409586183ca, content=请问不是妇科肿瘤可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e7d5293588, createdName=1486b608m27暂无昵称, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578501, encodeId=b8785e850104, content=收版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2019-10-25 147612bem32暂无昵称

收版面费

318 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务